Remote Jobs at Veristat
Veristat
Biotechnology • Pharmaceuticals • Science
Veristat is a specialty Contract Research Organization (CRO) that offers comprehensive clinical trial and consulting services. Particularly focused on the pharmaceutical and biotechnology sectors, Veristat supports their clients' development and regulatory strategy for complex and novel therapies. The company's expertise spans biologics, gene therapies, rare diseases, and regulatory submissions. Their services include full-service clinical trial planning, clinical trial conduct, and regulatory affairs, with a strong emphasis on adaptive designs, biostatistics, and pharmacovigilance. Veristat has been pivotal in advancing therapies through strategic consulting and clinical operations, from oncology and neurology to infectious diseases.
November 27
Leading commercial operations and strategic initiatives at Veristat with a focus on process excellence. Guiding executive reporting, team alignment, and project management for impactful commercial strategies.
🇬🇧 United Kingdom – Remote
💰 Private Equity Round on 2021-04
⏰ Full Time
🟠 Senior
⚙️ Operations
🇬🇧 UK Skilled Worker Visa Sponsor
October 10
Principal Biostatistician at Veristat providing statistical input on Phase I-IV clinical trial development and leading statistical analyses. Collaborating on clinical trial data and reporting results.
🍂 Massachusetts – Remote
💰 Private Equity Round on 2021-04
⏰ Full Time
🔴 Lead
🧪 Clinical Research
🦅 H1B Visa Sponsor
August 21
Principal Medical Writer at Veristat drives regulatory writing across development stages, ensuring ICH compliance; collaborates with cross-functional teams to deliver high-quality medical communications.
August 14
Leads multi-project clinical trials at Veristat, a CRO accelerating life-changing therapies. Interfaces across clinical research functions and external sponsors.
August 10
Senior Medical Writer at Veristat; plans regulatory documents for product development. Collaborates with cross-functional teams to ensure ICH compliance.
